Highbridge Capital Management’s St Jude Medical STJ Stock Holding History

Highbridge Capital Management’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-34,366	Closed	-$2.75M	–	1917
2016 Q4	$2.75M	Sell	34,366 -116,146	-77%	-$9.22M	0.05%	332
2016 Q3	$12M	Sell	150,512 -129,488	-46%	-$10.5M	0.19%	129
2016 Q2	$21.8M	Buy	+280,000	New	+$20M	0.36%	73
2015 Q3	–	Sell	-64,727	Closed	-$4.73M	–	2002
2015 Q2	$4.73M	Sell	64,727 -145,057	-69%	-$10.5M	0.06%	322
2015 Q1	$13.7M	Buy	+209,784	New	+$13.9M	0.19%	144
2014 Q4	–	Sell	-258,721	Closed	-$15.6M	–	1590
2014 Q3	$15.6M	Buy	+258,721	New	+$16.9M	0.21%	137
2014 Q2	–	Sell	-135,438	Closed	-$8.86M	–	1402
2014 Q1	$8.86M	Buy	+135,438	New	+$8.82M	0.11%	203

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Highbridge Capital Management's STJ Position: Q1 2017 in Review

Highbridge Capital Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 34,366 shares — an estimated $2.75M sold.

Highbridge Capital Management first reported a position in STJ in Q1 2014 and held it in 7 quarters. The position peaked at $21.8M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Highbridge Capital Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Highbridge Capital Management sold 34,366 St Jude Medical shares in Q1 2017, an estimated $2.75M.
Highbridge Capital Management first reported a position in St Jude Medical in Q1 2014 and held it in 7 quarters.
Highbridge Capital Management's St Jude Medical position peaked at $21.8M in Q2 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Highbridge Capital Management's 13F filing for Q1 2017, filed 15 May 2017.